Cancer clinical trials in the region Normandie

121 currently recruiting clinical trials
Region Normandie

Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 2 3 or more
Systemic Treatment-Naive
Abbvie
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 2 3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR
Bristol-Myers Squibb
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
AstraZeneca
Phase 3 Lung cancer
#NCT05078047
Locally Advanced Metastatic Immunotherapy
Centre François Baclesse (Caen ), Centre Hospitalier Intercommunal Elbeuf - Louviers - Val de Reuil (Saint-Aubin-lès-Elbeuf), Centre Hospitalier Mémorial de Saint-Lô (Saint-Lô)
UNICANCER
Phase 3 Stomach and esophageal cancer
#NCT05078047
Stomach Oesogastric junction Esophagus Adenocarcinoma Squamous cell carcinoma Locally Advanced Metastatic Immunotherapy
Centre François Baclesse (Caen ), Centre Hospitalier Intercommunal Elbeuf - Louviers - Val de Reuil (Saint-Aubin-lès-Elbeuf), Centre Hospitalier Mémorial de Saint-Lô (Saint-Lô)
UNICANCER